HIV

Surescripts settlement commentary

Pharma

Gilead inks Biktarvy settlements with 3 generic drug makers

Thanks to new settlements with a trio of generic drug makers, Gilead Sciences has extended the expected life span of its lucrative HIV treatment.

Fraiser Kansteiner Oct 7, 2025 7:40am

Gilead

CDC 'strongly recommends' Gilead's HIV PrEP Yeztugo

Sep 19, 2025 11:22am

Gilead Sciences Choose U HIV awareness campaign

Gilead campaign urges people living with HIV to 'Choose U'

Sep 4, 2025 11:55am

GSK

GSK allows generic versions of cabotegravir for HIV treatment

Jul 15, 2025 2:16pm

Gilead Sciences

Gilead enlists Global Fund in access campaign for new PrEP med

Jul 9, 2025 4:42pm

Signage for the Department of Health and Human Services HHS headquarters is seen on April 02 2025 in Washington DC

Fierce Healthcare

Judge sides with states, blocking HHS reorg and mass layoffs

Jul 1, 2025 3:30pm